Ashvin Garlapati
Dermatology · Crown Point, INNPI 1417246851
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Pfizer at 50.5% of the total. Reporting peaked in 2019 at $6,575 and has fallen 90.1% since, to $653 in 2021.
Across 185 payments — averaging $66.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$6K
- E.r. Squibb & Sons, L.L.C.$3K
- Johnson & Johnson$512
- AbbVie$490
- Novartis$243
- Regeneron Healthcare Solutions, Inc.$200
- plus $1K from 23 others
Across 23 payments — averaging $6867.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$119K
- Incyte Corporation$20K
- E.r. Squibb & Sons, L.L.C.$19K
What the payments were for
- Consulting fees$3,36027%
- Speaking & faculty fees$5,97549%
- Food & beverage$2,74622%
- Education$2002%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 28 | $6,204 |
| E.r. Squibb & Sons, L.L.C. | 1 | $3,360 |
| Johnson & Johnson | 28 | $512 |
| AbbVie | 30 | $490 |
| Novartis | 12 | $243 |
| Regeneron Healthcare Solutions, Inc. | 9 | $200 |
| Galderma Laboratories, L.p. | 9 | $161 |
| Almirall LLC | 7 | $131 |
| Sun Pharmaceutical Industries Inc. | 7 | $104 |
| LEO Pharma Inc. | 7 | $98 |
| Lilly USA, LLC | 6 | $90 |
| Amgen | 4 | $89 |
| Mayne Pharma Commercial LLC | 5 | $80 |
| Dermira, Inc. | 4 | $68 |
| Sanofi | 4 | $62 |
| Bristol Myers Squibb | 3 | $53 |
| EPI Health, LLC | 2 | $49 |
| VYNE Pharmaceuticals Inc. | 2 | $42 |
| UCB, Inc. | 1 | $41 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $39 |
| Aclaris Therapeutics, Inc. | 2 | $31 |
| Encore Dermatology Inc. | 2 | $26 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Biofrontera Inc. | 1 | $18 |
| Mission Pharmacal Company | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Prugen, Inc. Pharmaceuticals | 3 | $13 |
| Merck | 1 | $12 |
| Promius Pharma LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EUCRISA$5,975
How this compares
$12,281 in reported general payments places this provider in the 80th percentile of 202 dermatology providers in Indiana.
Other dermatology in Crown Point
- Aleksandra FlorekCrown Point$26K
- Scott GuenthnerPlainfield$1.6M
- David RosmarinIndianapolis$1.1M
- Christopher ObeimeIndianapolis$907K
- Scott FretzinIndianapolis$794K
- Priya YoungIndianapolis$492K
- Jeffrey SassmannshausenFort Wayne$489K
- Nikolajs PerdueIndianapolis$302K
- Michael SheehanColumbus$297K
- Alfred KnableNew Albany$203K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.